Abstract:T cell immunodeficiency may be a common characteristic in acute myeloid leukemia (AML) and adoptive T cellular immunotherapy has a broad prospect for clinical treatment. γδ T cells is essential to anti-leukemia function through perforin (Perf) / granzyme B (Grmb) pathway and may become a new strategy for leukemia immunotherapy. However, γδ T cells have different functional subsets like regulatory cell subsets and relevant regulatory mechanism is still unknown. Programmed death-1 (PD-1) which is one of T cell inhibitory receptors may mediate T cell suppression and dysfunction in leukemia and relate to general regulatory T cells which express transcription factor forkhead box P3 (Foxp3). It would be interesting whether PD-1 pathway might involve in regulation of regulatory Foxp3+ γδ T cells. In this study, we first investigated the regulatory cell subsets of γδ T cells in patients with AML. The flow cytometry (FCM) was used to detect the expression proportions of γδ T cells and their subfamilies in peripheral blood of AML patients (including 15 cases of de novo AML, 5 cases of recurrent AML and 4 cases in complete remission (CR)). Real-time quantitative PCR(RQ-PCR)was used to detect the expression levels of PD-1, Foxp3, Grmb and Perf genes in the γδ T cells sorting by MACS technique from peripheral blood of de novo AML patients. Fifteen health individuals (HI) served as controls. The results showed decreasing trend of γδ T cell counts in AML patients. Compared with HI groups, higher expression levels of PD-1 gene in γδ T cells were found in de novo AML patients, while Grmb and Perf gene presented lower expression levels by RQ-PCR (P <0.05) (Figure A). The expression levels of PD-1 gene had a positive correlation to the Foxp3 gene in de novo AML group. It was noteworthy that we firstly found a novel PD-1+ Foxp3+ γδ T subset in peripheral blood of AML patients and HI controls with different frequencies. The proportions of Foxp3+ γδ T cells, PD1+ γδ T cells, and PD-1+ Foxp3+ γδ T cells were significantly higher either in de novo or the recurrent AML patients, respectively (P <0.05). The PD1+ Foxp3+ γδ T cells counts in AML patients showed the pattern as the recurrent AML > the de novo AML > the AML-CR groups (Figure B and C). In conclusion, a novel regulatory PD1+ Foxp3+ γδ T subset with lower expression levels of Grmb and Perf genes was found in peripheral blood of AML patients. Higher proportion of PD1+ Foxp3+ γδ T cells might influence the occurrence and development of AML.

[Treg Cells, FoxP3 and TGF-β Expression and Significance in Chronic Myeloid Leukemia].

Levels and Clinical Significance of Regulatory B Cells and T Cells in Acute Myeloid Leukemia

BOTH LOCAL EXPANSION AND MIGRATION ACCOUNT FOR TREG ACCUMULATION IN LEUKEMIC HEMATOPOIETIC MICROENVIRONMENT

Hyperfunction of CD4 CD25 Regulatory T Cells in De Novo Acute Myeloid Leukemia.

HIGH EXPRESSION WITH PD-1+FOXP3+Gamma Delta T REGULATORY SUBSETS IN CHRONIC MYELOID LEUKEMIA PATIENTS

Hypothesis: Tim-3/Galectin-9, A New Pathway for Leukemia Stem Cells Survival by Promoting Expansion of Myeloid-Derived Suppressor Cells and Differentiating into Tumor-Associated Macrophages

Aberrant expression of Treg-associated cytokine IL-35 along with IL-10 and TGF-β in acute myeloid leukemia.

Research progress of regulatory T cells in acute myeloid leukemia

The Alteration And Clinical Significance Of Th22/Th17/Th1 Cells In Patients With Chronic Myeloid Leukemia

Blocking Migration of Regulatory T Cells to Leukemic Hematopoietic Microenvironment Delays Disease Progression in Mouse Leukemia Model.

Single-cell sequencing unveils T-cell characteristic in acute myeloid leukemia

FLT3LG and IFITM3P6 Consolidate T Cell Activity in the Bone Marrow Microenvironment and Are Prognostic Factors in Acute Myelocytic Leukemia

Retraction Note: Selectively Frequent Expression of CXCR5 Enhances Resistance to Apoptosis in CD8+CD34+ T Cells from Patients with T-cell-lineage Acute Lymphocytic Leukemia

Decreased Level of Recent Thymic Emigrants in CD4+ and CD8+T Cells from CML Patients

Characteristic of TIGIT and DNAM-1 Expression on Foxp3+æ T Cells in AML Patients

Characteristic of TIGIT and DNAM-1 Expression on Foxp3+ <i>γδ</i> T Cells in AML Patients

Comprehensive analysis of the immune pattern of T cell subsets in chronic myeloid leukemia before and after TKI treatment

Regulatory T cells promote the stemness of leukemia stem cells through IL10 cytokine-related signaling pathway

Increased Expression of TIGIT/CD57 in Peripheral Blood/Bone Marrow NK Cells in Patients with Chronic Myeloid Leukemia

Expression of Novel Regulatory Cell Subsets of PD-1high Foxp3+ Γδ T Cells in De Novo AML

Bioinformatics analysis and identification of hub genes and immune-related molecular mechanisms in chronic myeloid leukemia